메뉴 건너뛰기




Volumn 83, Issue 4, 2008, Pages 485-488

55-Year-old woman with menopausal symptoms and a family history of breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

EID: 42249102595     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.4.485     Document Type: Article
Times cited : (2)

References (13)
  • 2
    • 0036673445 scopus 로고    scopus 로고
    • Mathematical modeling for breast cancer assessment: State of art and role in medicine
    • Rubinstein WS, O'Neill SM, Peters JA, Rittmeyer LJ, Stadler MP. Mathematical modeling for breast cancer assessment: state of art and role in medicine. Oncology. 2002;16(8):1082-1094.
    • (2002) Oncology , vol.16 , Issue.8 , pp. 1082-1094
    • Rubinstein, W.S.1    O'Neill, S.M.2    Peters, J.A.3    Rittmeyer, L.J.4    Stadler, M.P.5
  • 3
    • 24644456397 scopus 로고    scopus 로고
    • US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement [published correction appears in Ann Intern Med. 2005;143(7):547]. Ann Intern Med. 2005;143(5):355-361.
    • US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement [published correction appears in Ann Intern Med. 2005;143(7):547]. Ann Intern Med. 2005;143(5):355-361.
  • 4
    • 0032537990 scopus 로고    scopus 로고
    • Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
    • Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998;90(18):1371-1388.
    • (1998) J Natl Cancer Inst , vol.90 , Issue.18 , pp. 1371-1388
    • Fisher, B.1    Costantino, J.P.2    Wickerham, D.L.3
  • 5
    • 85136390255 scopus 로고    scopus 로고
    • Vogel VG, Costantino JP, Wickerham DL, National Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of Tamoxifen vs Raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. JAMA. 2006 Jun 21;295(23):2727-2741. Epub 2006 Jun 5.
    • Vogel VG, Costantino JP, Wickerham DL, National Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of Tamoxifen vs Raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. JAMA. 2006 Jun 21;295(23):2727-2741. Epub 2006 Jun 5.
  • 6
    • 84900372781 scopus 로고    scopus 로고
    • US Food and Drug Administration, Center for Devices and Radiologic Health. Mammography: information for mammography facility personnel, inspectors, and consumers about the implementation of the Mammography Quality Standards Act of 1992 (MQSA). http://www.fda.gov/cdrh/mammography. Accessed March 5, 2008.
    • US Food and Drug Administration, Center for Devices and Radiologic Health. Mammography: information for mammography facility personnel, inspectors, and consumers about the implementation of the Mammography Quality Standards Act of 1992 (MQSA). http://www.fda.gov/cdrh/mammography. Accessed March 5, 2008.
  • 7
    • 84900355131 scopus 로고    scopus 로고
    • National Council on Radiation Protection and Measurements (NCRP). Report No. 149. A Guide to Mammography and Other Breast Imaging Procedures. Issued December 31, 2004. http://www.knovel.com/web/portal /basic_search/display?_EXT_KNOVEL_DISPLAY_bookid=1635. Accessed March 6, 2008.
    • National Council on Radiation Protection and Measurements (NCRP). Report No. 149. A Guide to Mammography and Other Breast Imaging Procedures. Issued December 31, 2004. http://www.knovel.com/web/portal /basic_search/display?
  • 8
    • 0037404722 scopus 로고    scopus 로고
    • Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666
    • Berg WA. Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666. AJR Am J Roentgenol. 2003;180(5):1225-1228.
    • (2003) AJR Am J Roentgenol , vol.180 , Issue.5 , pp. 1225-1228
    • Berg, W.A.1
  • 10
    • 0035861037 scopus 로고    scopus 로고
    • Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
    • King M, Wieand S, Hale K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA. 2001;286(18):2251-2256.
    • (2001) JAMA , vol.286 , Issue.18 , pp. 2251-2256
    • King, M.1    Wieand, S.2    Hale, K.3
  • 11
    • 0037015185 scopus 로고    scopus 로고
    • Breast cancer screening: A summary of the evidence for the US Preventive Services Task Force
    • Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137(5, pt 1):347-360.
    • (2002) Ann Intern Med , vol.137 , Issue.5 and PART 1 , pp. 347-360
    • Humphrey, L.L.1    Helfand, M.2    Chan, B.K.S.3    Woolf, S.H.4
  • 12
    • 0031842673 scopus 로고    scopus 로고
    • Radiation risk of mammography related to benefit in screening programmes: A favourable balance?
    • Beemsterboer PM, Warmerdam PG, Boer R, de Koning HJ. Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J Med Screen. 1998;5(2):81-87.
    • (1998) J Med Screen , vol.5 , Issue.2 , pp. 81-87
    • Beemsterboer, P.M.1    Warmerdam, P.G.2    Boer, R.3    de Koning, H.J.4
  • 13
    • 0031322032 scopus 로고    scopus 로고
    • Radiation risk from screening mammography of women aged 40-49 years
    • Feig SA, Hendrick RE. Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr. 1997;(22):119-124.
    • (1997) J Natl Cancer Inst Monogr , vol.22 , pp. 119-124
    • Feig, S.A.1    Hendrick, R.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.